Maximum quantity allowed is 999
Please select the quantity
CAS RN: 129618-40-2 | Product Number: N0922
Nevirapine
Purity: >98.0%(GC)
Synonyms:
- 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
Documents:
Size | Unit Price | Saitama (Kawaguchi) | Hyogo (Amagasaki) | Stock in other WH | Shipping Information |
---|---|---|---|---|---|
200MG |
¥12,000
|
It can be shipped in about 2-3 business days after ordering | ≥80 | Contact Us | |
1G |
¥38,000
|
8 | It can be shipped from Saitama warehouse on the same day* | Contact Us |
* Available Stock: Prompt shipment (for products) in Saitama/Hyogo warehouse. Stock In Other WH: Shipment in about 2-3 Business Days from Saitama warehouse. Please contact us
if you need further information.
* The displayed price is the unit price and does not include consumption tax. The unit prices displayed are the latest and are subject to change without notice.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
* The displayed price is the unit price and does not include consumption tax. The unit prices displayed are the latest and are subject to change without notice.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Note:
This product is a sample for RUO (research use only). Do not use this product for any purpose other than testing and research.
Product Number | N0922 |
Purity / Analysis Method | >98.0%(GC) |
Molecular Formula / Molecular Weight | C__1__5H__1__4N__4O = 266.30 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Frozen (<0°C) |
Condition to Avoid | Heat Sensitive |
Packaging and Container | 1G-Glass Bottle with Plastic Insert (View image), 200MG-Glass Bottle with Plastic Insert (View image) |
CAS RN | 129618-40-2 |
Reaxys Registry Number | 4757598 |
PubChem Substance ID | 160871291 |
Merck Index (14) | 6490 |
MDL Number | MFCD00866928 |
Specifications
Appearance | White to Light yellow powder to crystal |
Purity(GC) | min. 98.0 % |
Purity(Nonaqueous Titration) | min. 97.0 % |
Melting point | 244.0 to 248.0 °C |
Properties (reference)
Melting Point | 246 °C |
Solubility in water | Insoluble |
Degree of solubility in water | < 0.1 g/l |
GHS
Pictogram | |
Signal Word | Warning |
Hazard Statements | H302 : Harmful if swallowed. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
RTECS# | JM5562500 |
Transport Information:
Application
Nevirapine: A Non-Nucleoside Reverse Transcriptase Inhibitor
Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that active against HIV-1. Nevirapine selectively inhibits HIV-1 but not HIV-2 and any of the human DNA polymerases. Nucleoside reverse transcriptases (NRTIs) compete with natural nucleic acid triphosphates for inhibitory action, whereas nevirapine does not compete with the triphosphates. Nevirapine bind to an active site of the reverse transcriptase molecule of HIV-1, and inhibits the transcriptase activity. Therefore, nevirapine is also active against NRTI (e.g. azidothymidine) resistant HIV-1. (The product is for research purpose only.)
References
- Crystal structure at 3.5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor
- Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor
- Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors
- Nevirapine: a review of its development, pharmacological profile and potential for clinical use
PubMed Literature
Articles/Brochures
TCIMAIL
Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.